Breadcrumb navigation


Publications
Explore our latest technological advancements and discover NEC Bio's innovative approach to AI-driven drug development.
Featured Publication
ESMO2024: Oral DNA vaccination targeting personalised neoantigens in immune checkpoint inhibitor treated solid tumor patients - Interim results.
SITC2024: Randomized phase I trial of adjuvant individualized TG4050 vaccine in patients with locally advanced resected HPV-negative head and neck squamous cell carcinoma (HNSCC)
- Poster Number: 650
-
Authors: Christophe Le Tourneau, Jean-Pierre Delord, Ana Lalanne, Camille Jamet, Clementine Spring-Giusti, Annette Tavernaro, Berangere Bastien, Maud Brandely-Talbot, Eric Quemeneur, Kousuke Onoue, Yoshiko Yamashita, Naoko Yamagata, Kazuhide Onoguchi, Ivy Grace Pait, Brandon Malone, Oliver Baker, Per Ludvik Brattas, Olivier Lantz, Kaidre Bendjama, Christian Ottensmeier
SITC2024: Design of Enhanced TCRs Against Cancer Antigens Using an AI System
- Poster Number: 1230
-
Authors: Martin Renqiang Min, Tianxiao Li, Kazuhide Onoguchi, Daiki Mori, Jonathan Warrell, Pierre Machart, Anja Moesch, Andrea Meiser, Ivy Grace Pait, Ayako Okamura, Daisuke Muraoka, Hirokazu Matsushita, Kaidre Bendjama
White Paper
-Towards the realization of AI drug development-
Comprehensive process workflow for the commercial use of personalized cancer vaccines
NEC is committed to taking on the challenge of realizing new cancer treatments by aiming to establish an accurate, reliable, and comprehensive process workflow that utilizes AI and security technologies.
Publications / Presentations
- Apr 3, 2024
-
K Bendjama, "AI Empowered Infectious Disease Vaccine Development" 2024; The World Vaccine Congress Washington
- Mar 29, 2024
-
K Bendjama, "Towards realization of AI drug development:Comprehensive process workflow for the Commercial Use of Personalized Cancer Vaccines" 2024; NextGen Therapies Industry Working Group Summit
- Jul 27, 2023
-
Y Yamashita, "Utilization of Artificial Intelligence in vaccine development." 2023; The 39th Annual Meeting of the Japan Society of Drug Delivery System
- May 24, 2023
-
A Kitamura, "NEC's AI Drug Development Initiatives." 2023; 72nd SPSJ Annual Meeting
- Jul 23, 2021
-
Y Yamashita, "AI-based Neoantigen Prediction for Personalized Cancer Vaccine." 2021; The 57th Annual Meeting of Liver Cancer Study Group of Japan
- Jun 19, 2021
-
Y Yamashita, "AI-based Neoantigen Prediction for Personalized Cancer Vaccine." 2021; The 13th Annual Meeting of Japanese Society of Immunotherapy for Hematological Disorders
- May 23, 2021
-
Y Yamashita, K Bendjama, "AI-based Neoantigen Prediction for Personalized Cancer Vaccine." 2021; The 18th Annual Meeting of Japan Research Association for Immunotherapeutics
- Apr 16, 2021
-
Y Yamashita, "AI-based Neoantigen Prediction for Personalized Cancer Vaccine." 2021; Bring Innovation in the Pharmaceutical Industry
- Mar 5, 2021
-
Y Yamashita, "AI-based Neoantigen Prediction for Personalized Cancer Vaccine." 2021; The 4th Social Smart Dental Hospital Symposium
- Nov 29, 2019
-
Y Yamashita, "AI-based Neoantigen Prediction for Personalized Cancer Vaccine." 2019; The 32nd Annual Meeting of the Japan Society for Biological Therapy
- Aug 23, 2019
-
K Onoue, Y Yamashita, B Malone, Y Tanaka, B Grellier, K Bendjama, K Machida, and K Udaka, "Evaluation of HLA-peptide binding prediction method." 2019; The 23rd Annual Meeting of Japanese Association of Cancer Immunology